跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,777 条关于
“Rick R. Suarez”
全部
26,777
临床试验
20,229
药物
1,253
机构
355
资讯
4,940
8个月前
AstraZeneca Names Rick Suarez US President to Lead $50 Billion Investment Strategy
去年
P-BCMA-ALLO1 Demonstrates Promising Efficacy and Safety in Relapsed/Refractory Multiple Myeloma
去年
Navtemadlin Shows Promise in JAK Inhibitor-Refractory Myelofibrosis
9个月前
Enliven Therapeutics Appoints Rick Fair as CEO to Lead ELVN-001 Through Phase 3 Trial
5个月前
Humacyte Appoints Rick McElheny as Senior VP of Business Development to Accelerate Bioengineered Tissue Partnerships
去年
Tafasitamab Plus Lenalidomide Approved in Mexico for R/R DLBCL
去年
Revumenib Combination Shows Promise in Relapsed/Refractory AML with Specific Genetic Alterations
去年
FDA Approves Revuforj (revumenib) for R/R Acute Leukemia with KMT2A Translocation
5年前
Subcutaneous Isatuximab Plus Pd Shows Promise in R/R Multiple Myeloma Treatment
去年
VERAXA Biotech Appoints Oncology Veteran Rick Austin as Chief Scientific Officer to Advance Novel Cancer Therapies
第 1 页,共 494 页
上一页
下一页